Prostatic Diseases  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00260611: Study of Oxaliplatin and Taxotere in Prostate Cancer

Completed
2
34
US
Oxaliplatin, eloxatin, Taxotere, Docefrez, Docetaxel
University of Pittsburgh, Sanofi
Prostate Cancer
09/07
09/07

Download Options